1603. Elderly Age, Underlying Malignancy and Diabetes (DM) Are Not Significant Risk Factors for Candidemia with Candida glabrata (CG) 
Session: Poster Abstract Session: Mycology - There's a Fungus Among Us: Epidemiology
Friday, October 28, 2016
Room: Poster Hall
Posters
  • Candida glabrata Risk factors ID Week Poster [10.20.2016].pdf (284.2 kB)
  • Background: The 2016 update of the clinical practice guideline for the management of candidasis recommends an echinocandin as initial therapy for treatment of candidemia in neutropenic and non-neutropenic patients. Fluconazole is acceptable as initial therpay only in patient who are hemodynamically stable, without prior azole exposure, and are not at increased risk for CG infections. Elderly patients or those with underlying malignancy or DM are defined as groups at high risk for CG infections. These risk factors include a wide range of patients, may lead to increased echinocandin use, and have not been consistently proven in prior studies. We sought to evaluate if elderly age (≥ 65 years), underlying malignancy and DM are risk factors for candidemia with CG at our institution.

    Methods: Adult patients with at least one positive blood culture for Candida species between 1/1/2013-12/31/2015 were included. Only the first episode of candidemia was included for patients with recurrent candidemia. Risk factors were analyzed using regression analysis.

    Results: A total of 147 patients were reviewed. CG: 47; non-CG: 100 (C. albicans: 52; C. parapsilosis: 25; C. dubliniensis: 6; C. tropicalis: 5; C. krusei: 5; other: 7). Demographics and outcomes are summarized in table 1. Risk factors and their association with CG candidemia are shown in table 2. Elderly age and DM met a priori p < 0.2 for inclusion in multivariate (MV) analysis, neither was found to be an independent predictor for CG candidemia in MV analysis (elderly age: p = 0.26; DM: p = 0.08).

    Table 1. Patient Demographics and Outcomes

    CG

    Non-CG

    p-Value

    Male (%)

    45

    46

    0.79

    Age (Years)

    60.1 ± 14.1

    56.9 ± 16.0

    0.24

    All-Cause Inpatient Mortality (%)

    21

    44

    0.01

    Length of Stay (Days)

    16 (4-98)

    19.5 (2-122)

    0.21

    Table 2. Univariate Analysis of Risk Factors Associated with CG candidemia

    OR (95% CI)

    p-Value

    Elderly Age

    1.7 (0.8-3.5)

    0.14

    Underlying Malignancy

    1.4 (0.7-3.0)

    0.32

    DM

    2.3 (1.0-5.1)

    0.04

    Conclusion: Contrary to recommendations from the candidiasis guideline, elderly age, underlying malignancy and DM were not significant risk factors for CG candidemia in our patients. Presence of these patient characteristics should not preclude the use of fluconazole as initial therapy.

    Zhe Han, PharmD1, Natasha Pettit, PharmD1 and Jennifer Pisano, MD2, (1)Pharmacy Services, The University of Chicago Medicine, Chicago, IL, (2)Infectious Diseases and Global Health, The University of Chicago Medicine, Chicago, IL

    Disclosures:

    Z. Han, None

    N. Pettit, None

    J. Pisano, None

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.